MOSCOW (Reuters) -A Russian Soyuz MS-28 spacecraft with two Russian cosmonauts and one NASA astronaut on board successfully docked with the International Space Station on Thursday, Russian space agency Roscosmos said.
But the agency later reported that the launch pad at the Baikonur Cosmodrome in Kazakhstan had sustained damage from the launch. It said the damage would be quickly repaired.
The Soyuz 2.1a rocket lifted off from the Baikonur Cosmodrome at 12:28 p.m. Moscow time (0928 GMT).
Late on Thursday, Russian news agencies quoted Roscosmos as saying the launch had taken place without incident, but damage was observed after an inspection of the launch area.
"Damage to a number of elements of the launch pad was detected. An assessment of the state of the launch complex is being conducted now," the agencies quoted Roscosmos as saying.
"All the necessary reserve elements are there to restore it and the damage will be eliminated very soon."
It said the crew was on board the station and in good health.
(Reporting by Anastasia Lyrchikova; Writing by Marina Bobrova; Editing by Andrew Osborn, Ron Popeski and Bill Berkrot)
latest_posts
- 1
Rights group: At least 2,500 deaths during protest crackdown in Iran - 2Israel approves death penalty law for Palestinians convicted of attacks
- 3The most effective method to Make a Dazzling Site in 5 Basic Advances
- 4Kona SUV: The Courageous Minimized That is Catching Hearts Around the world
- 5US FDA approves Kura-Kyowa's blood cancer therapy
- Toyota Motor Europe to roll out smart EV charging through new partnerships
- Which Film Has the Incomparable Melodic Score?
- 10 Moves toward Start Your Own Effective Business
- How did birds survive while dinosaurs went extinct?
- Chief of Staff Zamir warns IDF will collapse due to lack of manpower, raises 'ten red flags'
- Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
- 5 Family SUVs for 2024: Which One Accommodates Your Family's Needs\uff1f
- Extravagance SUVs for Seniors: Solace, Innovation, and Security
- Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
